PDT Partners’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,641
Closed -$84K 839
2022
Q3
$84K Sell
12,641
-31,090
-71% -$207K 0.01% 790
2022
Q2
$228K Sell
43,731
-28,091
-39% -$146K 0.02% 801
2022
Q1
$496K Buy
71,822
+35,915
+100% +$248K 0.04% 583
2021
Q4
$447K Buy
+35,907
New +$447K 0.03% 559